Solventum Corporation
SOLV | NYSE
$88.94
+$0.10 (+0.11%)
Sep 22, 2026, 2:09 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 |
|---|---|---|---|---|---|
Cash & Equivalents | 878M | 762M | 194M | 61M | 91M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 813M | 665M | 530M | 358M | 253M |
Receivables | 1.03B | 1.23B | 1.31B | 1.17B | 1.18B |
Inventory | 1.07B | 965M | 857M | 873M | 813M |
Other Current Assets | 881M | 293M | 155M | 126M | 108M |
Total Current Assets | 3.86B | 3.25B | 2.52B | 2.23B | 2.19B |
Property-Plant & Equipment | 1.33B | 1.62B | 1.46B | 1.32B | 1.31B |
Goodwill & Intangibles | 8.3B | 8.92B | 9.44B | 9.69B | 10.33B |
Total Long-Term Assets | 10.44B | 11.21B | 11.42B | 11.36B | 11.89B |
Total Assets | 14.29B | 14.46B | 13.94B | 13.59B | 14.08B |
Account Payables | 687M | 618M | 477M | 348M | 320M |
Deferred Revenue | 621M | 572M | 574M | 559M | n/a |
Short-Term Debt | n/a | 200M | n/a | 27M | n/a |
Other Current Liabilities | 1.83B | 659M | 365M | 312M | 732M |
Total Current Liabilities | 3.14B | 2.7B | 1.73B | 1.31B | 1.41B |
Long-Term Debt | 5.04B | 7.81B | 8.3B | n/a | n/a |
Other Long-Term Liabilities | 910M | 760M | -7.99B | 258M | 527M |
Total Long-Term Liabilities | 6.11B | 8.8B | 549M | 541M | 610M |
Total Liabilities | 9.25B | 11.5B | 2.28B | 1.85B | 2.02B |
Total Debt | 5.04B | 8.01B | 8.3B | 95M | 112M |
Book Value | 5.05B | 2.96B | 11.67B | 11.74B | 12.06B |
Book Value Per Share | 28.80 | 17.04 | 67.55 | 68.08 | 69.92 |
Common Stock | 2M | 2M | n/a | n/a | n/a |
Retained Earnings | 1.8B | 242M | n/a | n/a | n/a |
Comprehensive Income | -625M | -1.06B | -337M | -497M | -200M |
Shareholders Equity | 5.05B | 2.96B | 11.67B | 11.74B | 12.06B |
Total Investments | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove SOLV